Daxor corporation announces further acquisitions of its bva-100® blood volume analyzer by leading medical centers throughout the u.s.

New york, ny, dec. 10, 2020 (globe newswire) -- daxor corporation (nyse mkt: dxr), an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announces additional acquisitions of daxor's bva-100® blood volume analyzer at major medical centers across the u.s.
DXR Ratings Summary
DXR Quant Ranking